Abstract

IntroductionThe 2022 ESC Guidelines in Cardio-Oncology focused on cancer therapy-related cardiac dysfunction (CTR-CD), with the formal introduction of biomarkers in the classification and risk stratification of CTR-CD, in addition to...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call